DERMATA THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
DERMATA THERAPEUTICS, INC. (DRMA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $3.09 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-11-14
- DERMATA THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $3.09M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month |
|---|---|
| 2024-09-30 | $3.09M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |